Raised serum ferritin predicts non‐response to interferon and ribavirin treatment in patients with chronic hepatitis C infection

Abstract

Raised s-ferritin values predicate non-response to interferon-ribavirin therapy in hepatitis C patients. Response rate in C282Y mutation carriers seems greater than in non-carriers.